Literature DB >> 11202475

Lymphangioleiomyomatosis.

J Kelly1, J Moss.   

Abstract

Lymphangioleiomyomatosis (LAM), a rare disorder of unknown cause that occurs almost exclusively in women of childbearing years, is characterized microscopically by abnormal smooth muscle proliferation in the lung, lymphatics, and mediastinal, abdominal and lower cervical lymph nodes. LAM is associated with progressive dyspnea, recurrent pneumothoraces, chylous effusions, abdominal tumors (angiomyolipoma), and chylous ascites. Because of the predilection of this disease for young women, therapies to date have mainly involved hormonal manipulation. Although the efficacy of these therapies has not been established, the clinical course is more favorable in recent studies compared with earlier reports.

Entities:  

Mesh:

Year:  2001        PMID: 11202475     DOI: 10.1097/00000441-200101000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  15 in total

1.  Pathology analysis of a rare case of diffuse pulmonary lymphangiomatosis.

Authors:  Jin Zhao; Ruibin Wu; Yingying Gu
Journal:  Ann Transl Med       Date:  2016-03

2.  Multiple pneumothoraces during second and third trimesters as first presentation of lymphangioleiomyomatosis.

Authors:  Ruth McCartney; Nicola Facey; George Chalmers; Alan Mathers; Fiona Roberts; Gill Irvine; Kenneth Anderson
Journal:  Obstet Med       Date:  2009-05-22

3.  The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Authors:  Jay H Ryu; Joel Moss; Gerald J Beck; Jar-Chi Lee; Kevin K Brown; Jeffrey T Chapman; Geraldine A Finlay; Eric J Olson; Stephen J Ruoss; Janet R Maurer; Thomas A Raffin; Hannah H Peavy; Kevin McCarthy; Angelo Taveira-Dasilva; Francis X McCormack; Nilo A Avila; Rosamma M Decastro; Susan S Jacobs; Mario Stylianou; Barry L Fanburg
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

4.  Involvement of lymphatics in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Katsuya Tsukada; Xiong Cai; Souheil El-Chemaly; Joel Moss
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

Review 5.  Lymphatic involvement in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo M Taveira-Dasilva; Thomas N Darling; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

6.  T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

Authors:  Stephen A Boorjian; Yuri Sheinin; Paul L Crispen; Christine M Lohse; Bradley C Leibovich; Eugene D Kwon
Journal:  Urology       Date:  2009-06-07       Impact factor: 2.649

7.  Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.

Authors:  Hen Prizant; Manisha Taya; Irina Lerman; Allison Light; Aritro Sen; Soumya Mitra; Thomas H Foster; Stephen R Hammes
Journal:  Endocr Relat Cancer       Date:  2016-02-15       Impact factor: 5.678

8.  Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.

Authors:  Manisha Taya; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Briaunna Minor; Erin Gibbons; Stephen R Hammes
Journal:  Endocr Relat Cancer       Date:  2020-04       Impact factor: 5.678

9.  The loss of tuberin promotes cell invasion through the ß-catenin pathway.

Authors:  Elizabeth A Barnes; Heidi L Kenerson; Baldwin C Mak; Raymond S Yeung
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-30       Impact factor: 6.914

10.  Association of retroperitoneal lymphangioleiomyomatosis with endosalpingiosis: a case report.

Authors:  José Manuel Lorente Herce; Virgilio Ruiz Luque; José Aguilar Luque; Pablo Martínez García; Daniel Díaz Gómez
Journal:  Cases J       Date:  2009-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.